Hepatology

Cover image for Vol. 61 Issue 4

Early View (Online Version of Record published before inclusion in an issue)

Edited By: Michael H. Nathanson

Impact Factor: 11.19

ISI Journal Citation Reports © Ranking: 2013: 3/75 (Gastroenterology & Hepatology)

Online ISSN: 1527-3350

Associated Title(s): Clinical Liver Disease, Liver Transplantation

VIEW

  1. 1 - 99
  1. Correspondence

  2. Viral Hepatitis

    1. Adaptation of the hepatitis B virus core protein to CD8+ T-cell selection pressure

      Helenie Kefalakes, Bettina Budeus, Andreas Walker, Christoph Jochum, Gudrun Hilgard, Andreas Heinold, Falko M. Heinemann, Guido Gerken, Daniel Hoffmann and Joerg Timm

      Article first published online: 25 MAR 2015 | DOI: 10.1002/hep.27771

  3. Editorial

    1. Risk scores for hepatocellular carcinoma in chronic hepatitis B

      Morris Sherman, Ray W. Kim and James Dziura

      Article first published online: 25 MAR 2015 | DOI: 10.1002/hep.27765

  4. Viral Hepatitis

    1. Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes

      Hamish A. Innes, Scott A. McDonald, John F. Dillon, Sam Allen, Peter C. Hayes, David Goldberg, Peter R. Mills, Stephen T. Barclay, David Wilks, Heather Valerio, Ray Fox, Diptendu Bhattacharyya, Nicholas Kennedy, Judith Morris, Andrew Fraser, Adrian J. Stanley, Peter Bramley and Sharon J. Hutchinson

      Article first published online: 25 MAR 2015 | DOI: 10.1002/hep.27766

  5. Correspondence

    1. Liver disease in China: A long way to go

      Tian Yang, Han Zhang, Wan Yee Lau, Feng Shen and Meng-Chao Wu

      Article first published online: 25 MAR 2015 | DOI: 10.1002/hep.27769

  6. Liver Biology and Pathobiology

    1. Liver fibrosis occurs through dysregulation of MyD88-dependent innate B-cell activity

      Manoj Thapa, Raghavan Chinnadurai, Victoria M. Velazquez, Dana Tedesco, Elizabeth Elrod, Jin-Hwan Han, Prachi Sharma, Chris Ibegbu, Andrew Gewirtz, Frank Anania, Bali Pulendran, Mehul S. Suthar and Arash Grakoui

      Article first published online: 25 MAR 2015 | DOI: 10.1002/hep.27761

  7. Viral Hepatitis

    1. Drug-induced allergic hepatitis developed in mice when myeloid-derived suppressor cells were depleted prior to halothane treatment

      Mala Chakraborty, Aaron M. Fullerton, Kenrick Semple, Lynette S. Chea, William R. Proctor, Mohammed Bourdi, David E. Kleiner, Xiangbin Zeng, Pauline M. Ryan, Pradeep K. Dagur, Julia D. Berkson, Timothy P. Reilly and Lance R. Pohl

      Article first published online: 25 MAR 2015 | DOI: 10.1002/hep.27764

  8. Liver Injury and Regeneration

    1. Inhibition of wild-type p53-induced phosphatase 1 promotes liver regeneration in mice by direct activation of mammalian target of rapamycin

      Lingling Zhang, Leiming Liu, Zhiyong He, Guangbing Li, Junping Liu, Zhangfa Song, Hongchuan Jin, Karl Lenhard Rudolph, Huayu Yang, Yilei Mao, Lianfeng Zhang, Hongbing Zhang, Zhicheng Xiao and Zhenyu Ju

      Article first published online: 25 MAR 2015 | DOI: 10.1002/hep.27755

  9. Editorial

  10. Correspondence

    1. Reply

      Qilin Gu and Zongbin Cui

      Article first published online: 25 MAR 2015 | DOI: 10.1002/hep.27759

  11. Steatohepatitis and Metabolic Liver Disease

    1. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

      Mattias Ekstedt, Hannes Hagström, Patrik Nasr, Mats Fredrikson, Per Stål, Stergios Kechagias and Rolf Hultcrantz

      Article first published online: 23 MAR 2015 | DOI: 10.1002/hep.27368

  12. Correspondence

    1. The β-adrenoceptor agonist isoproterenol rescues acetaminophen-injured livers: Is it really safe?

      Zhuolin Zou, Zhonghai Shen, Yijing Cai, Yi Chen, Si Chen and Yongping Chen

      Article first published online: 23 MAR 2015 | DOI: 10.1002/hep.27374

  13. Review

  14. Liver Failure, Cirrhosis and Portal Hypertension

    1. Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats

      Shao-Jung Hsu, Fa-Yauh Lee, Sun-Sang Wang, I-Fang Hsin, Te-Yueh Lin, Hui-Chun Huang, Ching-Chih Chang, Chiao-Lin Chuang, Hsin-Ling Ho, Han-Chieh Lin and Shou-Dong Lee

      Article first published online: 23 MAR 2015 | DOI: 10.1002/hep.27679

  15. Liver Injury and Regeneration

    1. Low-molecular-weight fibroblast growth factor 2 attenuates hepatic fibrosis by epigenetic down-regulation of Delta-like1

      Ruo-Lang Pan, Li-Xin Xiang, Ping Wang, Xiao-Yuan Liu, Li Nie, Wendong Huang and Jian-Zhong Shao

      Article first published online: 23 MAR 2015 | DOI: 10.1002/hep.27649

  16. Correspondence

    1. Reply

      Chien-Hsieh Chiang and Kuo-Chin Huang

      Article first published online: 23 MAR 2015 | DOI: 10.1002/hep.27427

  17. Liver Biology and Pathobiology

    1. Liver X receptors balance lipid stores in hepatic stellate cells through Rab18, a retinoid responsive lipid droplet protein

      Fiona O'Mahony, Kevin Wroblewski, Sheila M. O'Byrne, Hongfeng Jiang, Kara Clerkin, Jihane Benhammou, William S. Blaner and Simon W. Beaven

      Article first published online: 23 MAR 2015 | DOI: 10.1002/hep.27645

  18. Autoimmune, Cholestatic and Biliary Disease

    1. Knockdown of ezrin causes intrahepatic cholestasis by the dysregulation of bile fluidity in the bile duct epithelium in mice

      Ryo Hatano, Kaori Akiyama, Atsushi Tamura, Shigekuni Hosogi, Yoshinori Marunaka, Michael J. Caplan, Yoshiyuki Ueno, Sachiko Tsukita and Shinji Asano

      Article first published online: 23 MAR 2015 | DOI: 10.1002/hep.27565

  19. Viral Hepatitis

    1. You have full text access to this OnlineOpen article
      Randomized trial of interferon- and ribavirin-free ombitasvir/paritaprevir/ritonavir in treatment-experienced hepatitis C virus–infected patients

      Kazuaki Chayama, Kazuo Notsumata, Masayuki Kurosaki, Ken Sato, Lino Rodrigues Jr., Carolyn Setze, Prajakta Badri, Tami Pilot-Matias, Regis A. Vilchez and Hiromitsu Kumada

      Article first published online: 23 MAR 2015 | DOI: 10.1002/hep.27705

  20. Correspondence

    1. Reply

      Jude A. Oben

      Article first published online: 23 MAR 2015 | DOI: 10.1002/hep.27758

  21. Reviews

    1. On fibrates and cholestasis: A review

      Nisanne S. Ghonem, David N. Assis and James L. Boyer

      Article first published online: 23 MAR 2015 | DOI: 10.1002/hep.27744

  22. Rapid Communication

    1. Ledipasvir/sofosbuvir regimens for chronic hepatitis C infection: Insights from a work productivity economic model from the United States

      Zobair M. Younossi, Yushan Jiang, Nathaniel J. Smith, Maria Stepanova and Rachel Beckerman

      Article first published online: 23 MAR 2015 | DOI: 10.1002/hep.27757

  23. Viral Hepatitis

    1. Late diagnosis of hepatitis C virus infection in the Chronic Hepatitis Cohort Study (CHeCS): Missed opportunities for intervention

      Anne C. Moorman, Jian Xing, Stephen Ko, Loralee B. Rupp, Fujie Xu, Stuart C. Gordon, Mei Lu, Philip R. Spradling, Eyasu H. Teshale, Joseph A. Boscarino, Vinutha Vijayadeva, Mark A. Schmidt, Scott D. Holmberg and for the CHeCS Investigators

      Article first published online: 20 MAR 2015 | DOI: 10.1002/hep.27365

  24. Correspondence

    1. Replay

      Cynthia Guy, Ayako Suzuki, Manal Abdelmalek, James Burchette and Anna Mae Diehl

      Article first published online: 20 MAR 2015 | DOI: 10.1002/hep.27430

  25. Clinical Observations in Hepatology

  26. Hepatobiliary Malignancies

    1. IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanism

      Daisaku Yamada, Sumera Rizvi, Nataliya Razumilava, Steven F. Bronk, Jaime I. Davila, Mia D. Champion, Mitesh J. Borad, Jorge A. Bezerra, Xin Chen and Gregory J. Gores

      Article first published online: 20 MAR 2015 | DOI: 10.1002/hep.27687

    2. CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice

      Yunching Chen, Rakesh R. Ramjiawan, Thomas Reiberger, Mei R. Ng, Tai Hato, Yuhui Huang, Hiroki Ochiai, Shuji Kitahara, Elizabeth C. Unan, Tejaswini P. Reddy, Christopher Fan, Peigen Huang, Nabeel Bardeesy, Andrew X. Zhu, Rakesh K. Jain and Dan G. Duda

      Article first published online: 20 MAR 2015 | DOI: 10.1002/hep.27665

    3. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma

      Chunping Wang, Huaming Wang, Wuwei Yang, Kaiwen Hu, Hui Xie, Ke-Qin Hu, Wenlin Bai, Zheng Dong, Yinying Lu, Zhen Zeng, Min Lou, Hong Wang, Xudong Gao, Xiujuan Chang, Linjing An, Jianhui Qu, Jin Li and Yongping Yang

      Article first published online: 20 MAR 2015 | DOI: 10.1002/hep.27548

  27. Steatohepatitis and Metabolic Liver Disease

    1. The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial

      Leon A. Adams, Darrell H. Crawford, Katherine Stuart, Michael J. House, Timothy G. St. Pierre, Malcolm Webb, Helena L.I. Ching, Jenny Kava, Michael Bynevelt, Gerry C. MacQuillan, George Garas, Oyekoya T. Ayonrinde, Trevor A. Mori, Kevin D. Croft, Xianwa Niu, Gary P. Jeffrey and John K. Olynyk

      Article first published online: 20 MAR 2015 | DOI: 10.1002/hep.27662

  28. Viral Hepatitis

    1. Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans

      Miklos Z. Molnar, Hazem M. Alhourani, Barry M. Wall, Jun L. Lu, Elani Streja, Kamyar Kalantar-Zadeh and Csaba P. Kovesdy

      Article first published online: 20 MAR 2015 | DOI: 10.1002/hep.27664

  29. Review

  30. Viral Hepatitis

    1. Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation

      Xavier Forns, Michael Charlton, Jill Denning, John G. McHutchison, William T. Symonds, Diana Brainard, Theo Brandt-Sarif, Paul Chang, Valerie Kivett, Lluís Castells, Martín Prieto, Robert J. Fontana, Thomas F. Baumert, Audrey Coilly, Maria Carlota Londoño and François Habersetzer

      Article first published online: 20 MAR 2015 | DOI: 10.1002/hep.27681

    2. Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus–coinfected patients with mild fibrosis in the short term

      Juan Macías, María Mancebo, Manuel Márquez, Dolores Merino, Francisco Téllez, Antonio Rivero, Miguel A. von Wichmann, Luis F. López-Cortés, Nicolás Merchante, Jesús Santos, Miguel Raffo, Montserrat Pérez-Pérez, Ángela Camacho, Jose A. Iribarren and Juan A. Pineda

      Article first published online: 20 MAR 2015 | DOI: 10.1002/hep.27674

  31. Editorial

  32. Hepatobiliary Malignancies

    1. Predictors of survival of patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib

      Massimo Iavarone, Giuseppe Cabibbo, Marco Biolato, Cristina Della Corte, Marcello Maida, Marco Barbara, Michele Basso, Sara Vavassori, Antonio Craxì, Antonio Grieco, Carlo Cammà and Massimo Colombo

      Article first published online: 20 MAR 2015 | DOI: 10.1002/hep.27729

  33. Liver Failure, Cirrhosis and Portal Hypertension

    1. Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort)

      Jean-Claude Trinchet, Valérie Bourcier, Cendrine Chaffaut, Mohand Ait Ahmed, Setty Allam, Patrick Marcellin, Dominique Guyader, Stanislas Pol, Dominique Larrey, Victor De Lédinghen, Denis Ouzan, Fabien Zoulim, Dominique Roulot, Albert Tran, Jean-Pierre Bronowicki, Jean-Pierre Zarski, Odile Goria, Paul Calès, Jean-Marie Péron, Laurent Alric, Marc Bourlière, Philippe Mathurin, Jean-Frédéric Blanc, Armand Abergel, Lawrence Serfaty, Ariane Mallat, Jean-Didier Grangé, Catherine Buffet, Yannick Bacq, Claire Wartelle, Thông Dao, Yves Benhamou, Christophe Pilette, Christine Silvain, Christos Christidis, Dominique Capron, Gérard Thiefin, Sophie Hillaire, Vincent Di Martino, Pierre Nahon, Sylvie Chevret and and the ANRS CO12 CirVir Group

      Article first published online: 20 MAR 2015 | DOI: 10.1002/hep.27743

  34. Viral Hepatitis

    1. Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography–defined subclinical cirrhosis

      Mi Na Kim, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Ki Jun Song, Young Nyun Park and Kwang-Hyub Han

      Article first published online: 20 MAR 2015 | DOI: 10.1002/hep.27735

  35. Hepatobiliary Malignancies

    1. The role of hepatic resection in the treatment of hepatocellular cancer

      Sasan Roayaie, Ghalib Jibara, Parissa Tabrizian, Joong-Won Park, Jijin Yang, Lunan Yan, Myron Schwartz, Guohong Han, Francesco Izzo, Mishan Chen, Jean-Frédéric Blanc, Philip Johnson, Masatoshi Kudo, Lewis R. Roberts and Morris Sherman

      Article first published online: 20 MAR 2015 | DOI: 10.1002/hep.27745

  36. Hepatology Elsewhere

  37. Correspondence

  38. Viral Hepatitis

    1. Improvement of predictive models of risk of disease progression in chronic hepatitis C by incorporating longitudinal data

      Monica A. Konerman, Yiwei Zhang, Ji Zhu, Peter D.R. Higgins, Anna S.F. Lok and Akbar K. Waljee

      Article first published online: 20 MAR 2015 | DOI: 10.1002/hep.27750

  39. Hepatobiliary Malignancies

    1. Downstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteria

      Francis Y. Yao, Neil Mehta, Jennifer Flemming, Jennifer Dodge, Bilal Hameed, Oren Fix, Ryutaro Hirose, Nicholas Fidelman, Robert K. Kerlan Jr. and John P. Roberts

      Article first published online: 20 MAR 2015 | DOI: 10.1002/hep.27752

  40. Hepatology Elsewhere

  41. Correspondence

    1. Reply

      Kyung Mook Choi and Ho Cheol Hong

      Article first published online: 20 MAR 2015 | DOI: 10.1002/hep.27751

  42. Editorial

    1. Ezrin finds its groove in cholangiocytes

      Laura Fouassier and Romina Fiorotto

      Article first published online: 19 MAR 2015 | DOI: 10.1002/hep.27675

  43. Correspondence

    1. GLI2 as a marker of hedgehog-responsive cells

      Candice Alexandra Grzelak, Nicholas David Sigglekow and Geoffrey William McCaughan

      Article first published online: 19 MAR 2015 | DOI: 10.1002/hep.27432

  44. Review

  45. Editorial

  46. Comments from the Editors

  47. Clinical Observations in Hepatology

  48. Viral Hepatitis

    1. Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials

      Zobair M. Younossi, Maria Stepanova, Patrick Marcellin, Nezam Afdhal, Kris V. Kowdley, Stefan Zeuzem and Sharon L. Hunt

      Article first published online: 18 MAR 2015 | DOI: 10.1002/hep.27724

  49. Clinical Observations in Hepatology

  50. Hepatobiliary Malignancies

    1. DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma

      Augusto Villanueva, Anna Portela, Sergi Sayols, Carlo Battiston, Yujin Hoshida, Jesús Méndez-González, Sandrine Imbeaud, Eric Letouzé, Virginia Hernandez-Gea, Helena Cornella, Roser Pinyol, Manel Solé, Josep Fuster, Jessica Zucman-Rossi, Vincenzo Mazzaferro, Manel Esteller, Josep M. Llovet and on behalf of the HEPTROMIC Consortium

      Article first published online: 18 MAR 2015 | DOI: 10.1002/hep.27732

  51. Master's Perspective

  52. Correspondence

    1. FIB-4 as a prognostic model for patients with hepatitis B–associated hepatocellular carcinoma

      Qing Pang, Xin Sen Xu, Jing Yao Zhang, Kai Qu, Wei Chen and Chang Liu

      Article first published online: 18 MAR 2015 | DOI: 10.1002/hep.27727

  53. Editorial

  54. Viral Hepatitis

    1. Differentiation of acute from chronic hepatitis C virus infection by nonstructural 5B deep sequencing: A population-level tool for incidence estimation

      Vincent Montoya, Andrea D. Olmstead, Naveed Z. Janjua, Patrick Tang, Jason Grebely, Darrel Cook, P. Richard Harrigan and Mel Krajden

      Article first published online: 18 MAR 2015 | DOI: 10.1002/hep.27734

  55. Liver Biology and Pathobiology

    1. Interaction of tetraspan(in) TM4SF5 with CD44 promotes self-renewal and circulating capacities of hepatocarcinoma cells

      Doohyung Lee, Juri Na, Jihye Ryu, Hye-Jin Kim, Seo Hee Nam, Minkyung Kang, Jae Woo Jung, Mi-Sook Lee, Haeng Eun Song, Jungeun Choi, Gyu-Ho Lee, Tai Young Kim, June-Key Chung, Ki Hun Park, Sung-Hak Kim, Hyunggee Kim, Howon Seo, Pilhan Kim, Hyewon Youn and Jung Weon Lee

      Article first published online: 18 MAR 2015 | DOI: 10.1002/hep.27721

    2. Exome sequencing in HFE C282Y homozygous men with extreme phenotypes identifies a GNPAT variant associated with severe iron overload

      Christine E. McLaren, Mary J. Emond, V. Nathan Subramaniam, Pradyumna D. Phatak, James C. Barton, Paul C. Adams, Justin B. Goh, Cameron J. McDonald, Lawrie W. Powell, Lyle C. Gurrin, Katrina J. Allen, Deborah A. Nickerson, Tin Louie, Grant A. Ramm, Gregory J. Anderson and Gordon D. McLaren

      Article first published online: 18 MAR 2015 | DOI: 10.1002/hep.27711

  56. Hepatobiliary Malignancies

    1. Tumor-infiltrating, interleukin-33–producing effector-memory CD8+ T cells in resected hepatocellular carcinoma prolong patient survival

      Stefan M. Brunner, Christoph Rubner, Rebecca Kesselring, Maria Martin, Eva Griesshammer, Petra Ruemmele, Thomas Stempfl, Andreas Teufel, Hans J. Schlitt and Stefan Fichtner-Feigl

      Article first published online: 18 MAR 2015 | DOI: 10.1002/hep.27728

  57. Autoimmune, Cholestatic and Biliary Disease

    1. Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis

      Yongyin Li, Weibin Wang, Libo Tang, Xuanqiu He, Xin Yan, Xiaoyong Zhang, Youfu Zhu, Jian Sun, Yongquan Shi, Xiong Ma, Ian R. Mackay, M. Eric Gershwin, Ying Han and Jinlin Hou

      Article first published online: 18 MAR 2015 | DOI: 10.1002/hep.27725

  58. Viral Hepatitis

    1. Characterization of the genotype and integration patterns of hepatitis B virus in early- and late-onset hepatocellular carcinoma

      Hongli Yan, Yuan Yang, Ling Zhang, Guannan Tang, YuZhao Wang, Geng Xue, Weiping Zhou and Shuhan Sun

      Article first published online: 18 MAR 2015 | DOI: 10.1002/hep.27722

    2. Long-term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus–related cirrhosis

      Jeong Won Jang, Jong Young Choi, Young Seok Kim, Hyun Young Woo, Sung Kyu Choi, Chang Hyeong Lee, Tae Yeob Kim, Joo Hyun Sohn, Won Young Tak and Kwang-Hyub Han

      Article first published online: 18 MAR 2015 | DOI: 10.1002/hep.27723

    3. Cost-effectiveness of hepatitis C treatment for patients in early stages of liver disease

      Andrew J. Leidner, Harrell W. Chesson, Fujie Xu, John W. Ward, Philip R. Spradling and Scott D. Holmberg

      Article first published online: 16 MAR 2015 | DOI: 10.1002/hep.27736

  59. Liver Biology and Pathobiology

  60. Correspondence

    1. Reply

      Annalisa Berzigotti, Maria Reig and Jordi Bruix

      Article first published online: 10 MAR 2015 | DOI: 10.1002/hep.27701

  61. Review

  62. Liver Injury and Regeneration

    1. Resolution of liver fibrosis requires myeloid cell–driven sinusoidal angiogenesis

      Chahrazade Kantari-Mimoun, Magali Castells, Ralph Klose, Anna-Katharina Meinecke, Ursula J. Lemberger, Pierre-Emmanuel Rautou, Hélène Pinot-Roussel, Cécile Badoual, Katrin Schrödter, Christoph H. Österreicher, Joachim Fandrey and Christian Stockmann

      Article first published online: 10 MAR 2015 | DOI: 10.1002/hep.27635

  63. Steatohepatitis and Metabolic Liver Disease

    1. Activation of aryl hydrocarbon receptor dissociates fatty liver from insulin resistance by inducing fibroblast growth factor 21

      Peipei Lu, Jiong Yan, Ke Liu, Wojciech G. Garbacz, Pengcheng Wang, Meishu Xu, Xiaochao Ma and Wen Xie

      Article first published online: 27 FEB 2015 | DOI: 10.1002/hep.27719

  64. Liver Biology and Pathobiology

    1. A clinicopathological cohort study of liver pathology in 301 patients with human immunodeficiency virus/acquired immune deficiency syndrome

      Mark W. Sonderup, Helen Wainwright, Pauline Hall, Henry Hairwadzi and C. Wendy N. Spearman

      Article first published online: 27 FEB 2015 | DOI: 10.1002/hep.27710

  65. Liver Failure, Cirrhosis and Portal Hypertension

    1. Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis

      Cynthia Tsien, Gangarao Davuluri, Dharmvir Singh, Allawy Allawy, Gabriella A.M. Ten Have, Samjhana Thapaliya, John M. Schulze, David Barnes, Arthur J. McCullough, Marielle P.K.J. Engelen, Nicolaas E.P. Deutz and Srinivasan Dasarathy

      Article first published online: 27 FEB 2015 | DOI: 10.1002/hep.27717

  66. Steatohepatitis and Metabolic Liver Disease

    1. Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids

      Bianca M. Arendt, Elena M. Comelli, David W.L. Ma, Wendy Lou, Anastasia Teterina, TaeHyung Kim, Scott K. Fung, David K.H. Wong, Ian McGilvray, Sandra E. Fischer and Johane P. Allard

      Article first published online: 27 FEB 2015 | DOI: 10.1002/hep.27695

  67. Correspondence

    1. Should surgery be carried out in patients with hepatocellular carcinoma with portal hypertension?

      Tian Yang, Wan Yee Lau, Han Zhang, Mengchao Wu and Feng Shen

      Article first published online: 27 FEB 2015 | DOI: 10.1002/hep.27703

  68. Viral Hepatitis

    1. How to optimize hepatitis C virus treatment impact on life years saved in resource-constrained countries

      Dorothée Obach, Yazdan Yazdanpanah, Gamal Esmat, Anchalee Avihingsanon, Sahar Dewedar, Nicolas Durier, Alain Attia, Wagida A. Anwar, Anthony Cousien, Pisit Tangkijvanich, Serge Paul Eholié, Wahid Doss, Aya Mostafa, Arnaud Fontanet, Mostafa K. Mohamed and Sylvie Deuffic-Burban

      Article first published online: 27 FEB 2015 | DOI: 10.1002/hep.27691

      Corrected by:

      Erratum: Erratum

  69. Liver Biology and Pathobiology

  70. Viral Hepatitis

    1. Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study)

      Willem Pieter Brouwer, Qing Xie, Milan J. Sonneveld, Ningping Zhang, Qin Zhang, Fehmi Tabak, Adrian Streinu-Cercel, Ji-Yao Wang, Ramazan Idilman, Hendrik W. Reesink, Mircea Diculescu, Krzysztof Simon, Mihai Voiculescu, Meral Akdogan, Wlodzimierz Mazur, Jurrien G.P. Reijnders, Elke Verhey, Bettina E. Hansen, Harry L.A. Janssen and for the ARES Study Group

      Article first published online: 27 FEB 2015 | DOI: 10.1002/hep.27586

  71. Clinical Perspectives in Hepatology

    1. Safety of long-term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection

      Michele Barone, Antonella Notarnicola, Giuseppe Lopalco, Maria Teresa Viggiani, Francesco Sebastiani, Michele Covelli, Florenzo Iannone, Alfonso W. Avolio, Alfredo Di Leo, Luca Cantarini and Giovanni Lapadula

      Article first published online: 24 FEB 2015 | DOI: 10.1002/hep.27716

  72. Autoimmune, Cholestatic and Biliary Disease

  73. Hepatobiliary Malignancies

    1. You have full text access to this OnlineOpen article
      Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma

      Kim Andresen, Kirsten Muri Boberg, Hege Marie Vedeld, Hilde Honne, Peter Jebsen, Merete Hektoen, Christopher A. Wadsworth, Ole Petter Clausen, Knut E.A. Lundin, Vemund Paulsen, Aksel Foss, Øystein Mathisen, Lars Aabakken, Erik Schrumpf, Ragnhild A. Lothe and Guro E. Lind

      Article first published online: 24 FEB 2015 | DOI: 10.1002/hep.27707

  74. Correspondence

    1. Replay

      Chunping Wang, Ke-Qin Hu and Yongping Yang

      Article first published online: 24 FEB 2015 | DOI: 10.1002/hep.27713

  75. Clinical Observations in Hepatology

    1. Delayed hepatocellular carcinoma model for end-stage liver disease exception score improves disparity in access to liver transplant in the United States

      Julie K. Heimbach, Ryutaro Hirose, Peter G. Stock, David P. Schladt, Hui Xiong, Jiannong Liu, Kim M. Olthoff, Ann Harper, Jon J. Snyder, Ajay K. Israni, Bertram L. Kasiske and W. Ray Kim

      Article first published online: 24 FEB 2015 | DOI: 10.1002/hep.27704

  76. Liver Failure, Cirrhosis and Portal Hypertension

    1. Attenuated portal hypertension in germ-free mice: Function of bacterial flora on the development of mesenteric lymphatic and blood vessels

      Sheida Moghadamrad, Kathy D. McCoy, Markus B. Geuking, Hans Sägesser, Jorum Kirundi, Andrew J. Macpherson and Andrea De Gottardi

      Article first published online: 24 FEB 2015 | DOI: 10.1002/hep.27698

  77. Correspondence

  78. Viral Hepatitis

    1. Experimental transmission of equine hepacivirus in horses as a model for hepatitis C virus

      Joshua D. Ramsay, Ryan Evanoff, Tom E. Wilkinson Jr., Thomas J. Divers, Donald P. Knowles and Robert H. Mealey

      Article first published online: 24 FEB 2015 | DOI: 10.1002/hep.27689

  79. Hepatobiliary Malignancies

    1. Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms

      Bani Mukhopadhyay, Kornel Schuebel, Partha Mukhopadhyay, Resat Cinar, Grzegorz Godlewski, Keming Xiong, Ken Mackie, Martin Lizak, Qiaoping Yuan, David Goldman and George Kunos

      Article first published online: 17 FEB 2015 | DOI: 10.1002/hep.27686

  80. Correspondence

    1. The case for cost-effectively treating cryoglobulinemic vasculitis with interferon-free anti–hepatitis C virus therapy

      Marcella Visentini, Stefania Colantuono, Guido Granata, Adriano de Santis, Massimo Fiorilli and Milvia Casato

      Article first published online: 17 FEB 2015 | DOI: 10.1002/hep.27600

  81. Liver Failure, Cirrhosis and Portal Hypertension

    1. Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial

      Marta Cavallin, Patrick S. Kamath, Manuela Merli, Silvano Fasolato, Pierluigi Toniutto, Francesco Salerno, Mauro Bernardi, Roberto Giulio Romanelli, Cosimo Colletta, Freddy Salinas, Antonio Di Giacomo, Lorenzo Ridola, Ezio Fornasiere, Paolo Caraceni, Filippo Morando, Salvatore Piano, Angelo Gatta, Paolo Angeli and for the Italian Association for the Study of the Liver Study Group on Hepatorenal Syndrome

      Article first published online: 13 FEB 2015 | DOI: 10.1002/hep.27709

  82. Correspondence

  83. Hepatobiliary Malignancies

    1. Ubiquitin-specific protease 7 accelerates p14ARF degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression

      Jia-Bin Cai, Guo-Ming Shi, Zhao-Ru Dong, Ai-Wu Ke, Hong-Hui Ma, Qiang Gao, Zao-Zhuo Shen, Xiao-Yong Huang, Hao Chen, Ding-Dang Yu, Li-Xin Liu, Peng-Fei Zhang, Chi Zhang, Mei-Yu Hu, Liu-Xiao Yang, Ying-Hong Shi, Xiao-Ying Wang, Zhen-Bin Ding, Shuang-Jian Qiu, Hui-Chuan Sun, Jian Zhou, Yujiang G. Shi and Jia Fan

      Article first published online: 13 FEB 2015 | DOI: 10.1002/hep.27682

  84. Correspondence

  85. Reviews

    1. Potential of human induced pluripotent stem cells in studies of liver disease

      Fotios Sampaziotis, Charis-Patricia Segeritz and Ludovic Vallier

      Article first published online: 10 FEB 2015 | DOI: 10.1002/hep.27651

  86. Clinical Observations in Hepatology

    1. Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease

      Jeffrey B. Schwimmer, Michael S. Middleton, Cynthia Behling, Kimberly P. Newton, Hannah I. Awai, Melissa N. Paiz, Jessica Lam, Jonathan C. Hooker, Gavin Hamilton, John Fontanesi and Claude B. Sirlin

      Article first published online: 5 FEB 2015 | DOI: 10.1002/hep.27666

  87. Correspondence

    1. Reply

      Amy S. Lee and Wan-Ting Chen

      Article first published online: 24 DEC 2014 | DOI: 10.1002/hep.27405

VIEW

  1. 1 - 99

SEARCH

SEARCH BY CITATION